扫描下面的二维码:

二维码

"摘要赏析"标签列表

[APASL2013]HBV DNA Seroclearance Significantly Increases Rates of Spontaneous HBsAg Seroclearance in Chronic Hepatitis B Patients with Low Viral Loads2013-06-09

[APASL2013]HBV DNA血清清除显著增加低病毒载量慢性乙型肝炎患者自发性HBsAg转阴率2013-06-09

[APASL2013]A Clinical Trial on Anti-HBV-DC Vaccine Combined with Thymosin-α1 in the Inactive HBsAg Carriers2013-06-09

[APASL2013]非活动性HBsAg携带者抗HBV-DC疫苗联合胸腺肽α1治疗的临床试验2013-06-09

[APASL2013]A 96-week Randomized Trial of Switching to Entecavir in Chronic Hepatitis B Patients with a Complete Virologic Response to Lamivudine2013-06-08

[APASL2013]一项拉米夫定治疗获得完全病毒学应答的慢性乙型肝炎患者换用恩替卡韦的96周随机试验2013-06-08

[APASL2013]A Randomized, Three-arm Study to Optimize Lamivudine Efficacy in HBeAg Positive Chronic Hepatitis B (CHB) Patients: Week-72 EXPLORE Study Results2013-06-08

[APASL2013]一项优化拉米夫定治疗HBeAg阳性慢性乙型肝炎(CHB)患者疗效的随机,三臂研究:72周研究结果2013-06-08

[APASL2013]Comparison of Telbivudine Alone and in Combination with Thymosin-α1 in HBeAg-positive Chronic Hepatitis B2013-06-08

[APASL2013]替比夫定单药和联合胸腺肽α1治疗HBeAg阳性慢性乙型肝炎的比较2013-06-08

[APASL2013]S-Collate Cohort Study: Early On-treatment HBsAg Decline in ’Real Life’ Predicts HBsAg Clearance Post-treatment in Peginterferon Alfa-2a (40KD)-treated HBeAg-negative Patients2013-06-08

[APASL2013]S-Collate队列研究:“现实生活”中HBsAg的早期治疗下降预测聚乙二醇干扰素α-2a (40KD)治疗HBeAg阴性患者的HBsAg清除2013-06-08

[APASL2013]Combination of Lamivudine and Adefovir Initial Therapy and Lamivudine and Entecavir Monotherapy in Hepatitis B e Antigen-positive Chronic Hepatitis B2013-06-07

[APASL2013]初始联合拉米夫定和阿德福韦酯以及拉米夫定和恩替卡韦单药治疗HBeAg阳性慢性乙型肝炎2013-06-07

[APASL2013]Entecavir versus Other Standard-of-Care for up to 4 Years in Nucleos(t)ide-naïve Patients with CHB in a Chinese Clinical Practice Setting2013-06-07

[APASL2013]中国临床实践中恩替卡韦与其他标准疗法治疗核苷(酸)初治慢性乙肝患者长达4年的比较2013-06-07

[APASL2013]Vaccine Therapy in Hepatitis B Carriers: A Randomized Double Blind Clinical Trial2013-06-07

[APASL2013]乙肝携带者疫苗疗法:一项随机双盲临床试验2013-06-07

[APASL2013]Allogeneic Bone Marrow Mesenchymal Stem Cells Improves Outcomes of HBV Related Acute-on-Chronic Liver Failure2013-06-07

[APASL2013]异基因骨髓间充质干细胞改善HBV相关慢加急性肝功能衰竭预后2013-06-07



设为首页 | 加入收藏 | 网站地图 | 订阅杂志 | 关于我们 | 版权声明 | 联系方式|招贤纳士
国际肝病  版权所有  京ICP备15060708号   (京)-非经营性-2016-0001京公网安备 11010502033341号 2004-2020  www.ihepa.com  ALL Rights  Reserved

增值电信业务经营许可证:京B2-20212326

网站统计